129 related articles for article (PubMed ID: 9123529)
1. CMV causes bile duct destruction and arterial lesions in rat liver allografts.
Martelius T; Krogerus L; Höckerstedt K; Mäkisalo H; Bruggeman C; Lautenschlager I
Transplant Proc; 1997; 29(1-2):796-7. PubMed ID: 9123529
[No Abstract] [Full Text] [Related]
2. Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts.
Martelius T; Krogerus L; Höckerstedt K; Bruggeman C; Lautenschlager I
Hepatology; 1998 Apr; 27(4):996-1002. PubMed ID: 9537439
[TBL] [Abstract][Full Text] [Related]
3. A rat model of monitoring liver allograft rejection.
Martelius T; Mäkisalo H; Höckerstedt K; Taskinen E; Lautenschlager I
Transpl Int; 1997; 10(2):103-8. PubMed ID: 9089993
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus infection of bile duct epithelial cells, hepatic artery and portal venous endothelium in relation to chronic rejection of liver grafts.
Evans PC; Coleman N; Wreghitt TG; Wight DG; Alexander GJ
J Hepatol; 1999 Nov; 31(5):913-20. PubMed ID: 10580590
[TBL] [Abstract][Full Text] [Related]
5. Antiviral and immunomodulatory effects of desferrioxamine in cytomegalovirus-infected rat liver allografts with rejection.
Martelius T; Scholz M; Krogerus L; Höckerstedt K; Loginov R; Bruggeman C; Cinatl J; Doerr HW; Lautenschlager I
Transplantation; 1999 Dec; 68(11):1753-61. PubMed ID: 10609953
[TBL] [Abstract][Full Text] [Related]
6. Induction of cyclo-oxygenase-2 by acute liver allograft rejection and cytomegalovirus infection in the rat.
Martelius TJ; Wolff H; Bruggeman CA; Höckerstedt KA; Lautenschlager IT
Transpl Int; 2002 Dec; 15(12):610-4. PubMed ID: 12478407
[TBL] [Abstract][Full Text] [Related]
7. Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection.
Matsumoto Y; McCaughan GW; Painter DM; Bishop GA
Transplantation; 1993 Jul; 56(1):69-75. PubMed ID: 8333070
[TBL] [Abstract][Full Text] [Related]
8. Effect of cytomegalovirus infection on expression of HLA-antigens in liver allografts.
Arnold JC; Gmelin K; Otto G; Alexander GJ; Williams R
Transplant Proc; 1991 Feb; 23(1 Pt 1):442-3. PubMed ID: 1846715
[No Abstract] [Full Text] [Related]
9. Cytomegalovirus infection, viral DNA, and immediate early-1 gene expression in rejecting rat liver allografts.
Martelius TJ; Blok MJ; Inkinen KA; Loginov RJ; Höckerstedt KA; Bruggeman CA; Lautenschlager IT
Transplantation; 2001 May; 71(9):1257-61. PubMed ID: 11397959
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil monotherapy significantly decreases the immune response of acute rejection in rat liver allografts.
Martelius T; Lautenschlager I; Mäkisalo H; Höckerstedt K
Transplant Proc; 1997 Nov; 29(7):3153-4. PubMed ID: 9365705
[No Abstract] [Full Text] [Related]
11. CMV increases inflammation and accelerates chronic rejection in rat kidney allografts.
Lautenschlager I; Soots A; Krogerus L; Kauppinen H; Saarinen O; Bruggeman C; Ahonen J
Transplant Proc; 1997; 29(1-2):802-3. PubMed ID: 9123533
[No Abstract] [Full Text] [Related]
12. Diagnosis and grading of liver allograft rejection: a European perspective.
Hübscher S
Transplant Proc; 1996 Feb; 28(1):504-7. PubMed ID: 8644330
[No Abstract] [Full Text] [Related]
13. Persistent cytomegalovirus in liver allografts with chronic rejection.
Lautenschlager I; Höckerstedt K; Jalanko H; Loginov R; Salmela K; Taskinen E; Ahonen J
Hepatology; 1997 Jan; 25(1):190-4. PubMed ID: 8985289
[TBL] [Abstract][Full Text] [Related]
14. Reactivation of cytomegalovirus with acute rejection and cytomegalovirus infection with obliterative bronchiolitis in rat lung allografts.
Yagyu K; van Breda Vriesman PJ; Duijvestijn AM; Bruggeman CA; Steinhoff G
Transplant Proc; 1993 Feb; 25(1 Pt 2):1152-4. PubMed ID: 8382853
[No Abstract] [Full Text] [Related]
15. Rejection rate of a small bowel allografts is reduced by liver transplantation.
Meyer D; Gassel HJ; Timmermann W; Otto C; Ulrichs K; Thiede A
Transplant Proc; 2000 Sep; 32(6):1287. PubMed ID: 10995950
[No Abstract] [Full Text] [Related]
16. Different cellular patterns associated with hepatitis C virus reactivation, cytomegalovirus infection, and acute rejection in liver transplant patients monitored with transplant aspiration cytology.
Lautenschlager I; Nashan B; Schlitt HJ; Hoshino K; Ringe B; Tillmann HL; Manns M; Wonigeit K; Pichlmayr R
Transplantation; 1994 Dec; 58(12):1339-45. PubMed ID: 7809926
[TBL] [Abstract][Full Text] [Related]
17. Histologic findings associated with CMV infection in liver transplantation.
Lautenschlager I; Höckerstedt K; Taskinen E
Transplant Proc; 2003 Mar; 35(2):819. PubMed ID: 12644152
[No Abstract] [Full Text] [Related]
18. Predictive value of CD45RC mRNA for acute rejection in hepatic allografts in rats.
Shintaku S; Tashiro H; Yamamoto H; Fudaba Y; Shibata S; Okimasa S; Mizunuma K; Noriyuki T; Fukuda Y; Asahara T; Dohi K
Transplant Proc; 2000 Nov; 32(7):2360-2. PubMed ID: 11120200
[No Abstract] [Full Text] [Related]
19. Portal capillary destruction in liver allograft rejection.
Matsumoto Y; McCaughan GW; Bishop GA
Transplant Proc; 1992 Feb; 24(1):196-7. PubMed ID: 1539242
[No Abstract] [Full Text] [Related]
20. Effect of cytomegalovirus on an experimental model of chronic renal allograft rejection under triple-drug treatment in the rat.
Lautenschlager I; Soots A; Krogerus L; Kauppinen H; Saarinen O; Bruggeman C; Ahonen J
Transplantation; 1997 Aug; 64(3):391-8. PubMed ID: 9275101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
